237 related articles for article (PubMed ID: 16890705)
1. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of patients with familial versus sporadic prostate cancer.
Roehl KA; Loeb S; Antenor JA; Corbin N; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 1):2438-42; discussion 2442. PubMed ID: 17085123
[TBL] [Abstract][Full Text] [Related]
3. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
5. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
[TBL] [Abstract][Full Text] [Related]
6. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.
Roehl KA; Han M; Ramos CG; Antenor JA; Catalona WJ
J Urol; 2004 Sep; 172(3):910-4. PubMed ID: 15310996
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
[TBL] [Abstract][Full Text] [Related]
8. Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients.
Kawakami S; Fukui I; Yonese J; Okubo Y; Yamamoto S; Tsukamoto T; Ishikawa Y
Jpn J Clin Oncol; 2007 Jul; 37(7):528-33. PubMed ID: 17720739
[TBL] [Abstract][Full Text] [Related]
9. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
Porter CR; Kodama K; Gibbons RP; Correa R; Chun FK; Perrotte P; Karakiewicz PI
J Urol; 2006 Aug; 176(2):569-74. PubMed ID: 16813891
[TBL] [Abstract][Full Text] [Related]
10. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
Sengupta S; Christensen CM; Zincke H; Slezak JM; Leibovich BC; Bergstralh EJ; Myers RP; Blute ML
J Urol; 2006 Aug; 176(2):559-63. PubMed ID: 16813889
[TBL] [Abstract][Full Text] [Related]
11. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
[TBL] [Abstract][Full Text] [Related]
12. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
13. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2001 Aug; 166(2):416-9. PubMed ID: 11458039
[TBL] [Abstract][Full Text] [Related]
14. Familial and hereditary prostate cancer by definition in an italian surgical series: clinical features and outcome.
Sacco E; Prayer-Galetti T; Pinto F; Ciaccia M; Fracalanza S; Betto G; Pagano F
Eur Urol; 2005 Jun; 47(6):761-8. PubMed ID: 15925070
[TBL] [Abstract][Full Text] [Related]
15. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival.
Nguyen CT; Reuther AM; Stephenson AJ; Klein EA; Jones JS
J Urol; 2009 Jan; 181(1):75-80. PubMed ID: 19012927
[TBL] [Abstract][Full Text] [Related]
16. Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy.
Lee KL; Marotte JB; Ferrari MK; McNeal JE; Brooks JD; Presti JC
Urology; 2005 Feb; 65(2):311-5. PubMed ID: 15708044
[TBL] [Abstract][Full Text] [Related]
17. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Partin AW
J Urol; 2006 Oct; 176(4 Pt 1):1404-8. PubMed ID: 16952644
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study.
Hachiya T; Okada Y; Kawata N; Hirano D; Yoshida T; Okada K; Takimoto Y
Int J Urol; 2004 Oct; 11(10):862-9. PubMed ID: 15479291
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
20. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.
Gjertson CK; Asher KP; Sclar JD; Goluboff ET; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Oct; 70(4):723-7. PubMed ID: 17991544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
